189 related articles for article (PubMed ID: 31183628)
1. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
Shi D; Zhou Z; Dai Y; Pan X; Cao Q
Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
[TBL] [Abstract][Full Text] [Related]
2. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis.
Ma YJ; Cao ZX; Li Y; Feng SY
World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718
[TBL] [Abstract][Full Text] [Related]
4. Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
Lewis DS; Lee TH; Konanur M; Ziegler C; Hall MD; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Choi SS; Ronald J
J Vasc Interv Radiol; 2019 Feb; 30(2):163-169. PubMed ID: 30638914
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
Dai R; Sag AA; Martin JG; Befera NT; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Muir AJ; Ronald J
Clin Imaging; 2021 Sep; 77():187-192. PubMed ID: 33940357
[TBL] [Abstract][Full Text] [Related]
6. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis.
Su Y; Chen Y; Zheng J; Yao C
BMJ Open; 2024 Apr; 14(4):e078412. PubMed ID: 38569689
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Dam G; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
[TBL] [Abstract][Full Text] [Related]
9. Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis.
Gangwani MK; Ahmed Z; Ishtiaq R; Aziz M; Rani A; Dahiya DS; Priyanka F; Arif SF; Lee-Smith W; Sohail AH; Inamdar S; Hassan M
Minerva Gastroenterol (Torino); 2023 Oct; ():. PubMed ID: 37889110
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
Xu HB; Wang HD; Li CH; Ye S; Dong MS; Xia QJ; Zhang AQ; Pan K; Ge XL; Dong JH
Genet Mol Res; 2015 Jul; 14(3):7490-501. PubMed ID: 26214428
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Proton Pump Inhibitors and the Complications of Liver Cirrhosis: A Systematic Review and Meta-Analysis.
Hwang SJ; Lee DH; Koh SJ; Kim JW; Park HS; Kim BG; Lee KL
Turk J Gastroenterol; 2022 Jan; 33(1):44-52. PubMed ID: 35040787
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
[TBL] [Abstract][Full Text] [Related]
13. Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis.
Bian J; Wang A; Lin J; Wu L; Huang H; Wang S; Yang X; Lu X; Xu Y; Zhao H
Medicine (Baltimore); 2017 Apr; 96(17):e6723. PubMed ID: 28445288
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
Wong ZY; Koh JH; Muthiah M; Koh B; Ong EYH; Ong CEY; Ou KQ; Lim WH; Tan DJH; Chee D; Siah KTH; Wong Y; Kaewdech A; Wijarnpreecha K; Kulkarni AV; Nah B; Huang DQ; Noureddin M; Ng CH; Teng M
Dig Dis Sci; 2024 Jan; 69(1):289-297. PubMed ID: 37968557
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies.
Wu X; Zhang D; Yu Y; Lou L; Li X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32406491
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use and Complications of Cirrhosis Are Linked With Distinct Gut Microbial Bacteriophage and Eukaryotic Viral-Like Particle Signatures in Cirrhosis.
Peña Rodríguez M; Fagan A; Sikaroodi M; Gillevet PM; Bajaj JS
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00659. PubMed ID: 37937851
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]